Astron Peripheral Self-Expanding Nitinol Stent System
Biotronik AG · Decision date Sep 11, 2026
What did the FDA decide?
The FDA database lists decision OK30 on 2026-09-11 for P140030/S025, a 30-Day Notice supplement to the Astron Peripheral Self-Expanding Nitinol Stent System PMA (P140030). The applicant is Biotronik AG, and the supplement reason is recorded as a process change affecting manufacturer, sterilizer, packager or supplier, with device category STENT, ILIAC and product code NIO.
The stated scope is modifications to the Gold-plating manufacturing equipment. The record does not identify which equipment, what the modification was, or how it relates to stent production, so those specifics remain unknown. The S025 identifier ties the filing to the existing P140030 PMA rather than a new system approval, and the stated purpose of the notice is not independent evidence of safety or clinical effectiveness.
The decision code OK30 and the September 2026 date are as recorded in the supplied database fields; the entry provides no further rationale, review detail or outcome description beyond that code and date.
FDA approval order statement
modifications to the Gold-plating manufacturing equipment
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 11, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P140030/S025
- Regulatory pathway
- PMA supplement
- Applicant
- Biotronik AG
- Product code
- NIO
- Decision code
- OK30
- Decision date
- Sep 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Biotronik AG
- Product code
- NIO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P140030. Subsequent supplements may change the device or its indications.
FDA decision timeline
P140030 · Original PMA
ASTRON PERIPHERAL SELF-EXPANDING NITINOL STENT SYSTEM
P140030/S025 received
Application receipt date recorded by FDA.
P140030/S025 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P140030. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P140030
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biotronik AG | PMA approval | Dec 17, 2015 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
ZILVER VASCULAR STENTP050017 | Cook Ireland, Ltd. | PMA approval | Jun 26, 2006 | FDA |
INTRASTENT DOUBLESTRUT STENTP030045 | Medtronic Vascular, Inc. | PMA approval | Jun 8, 2004 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biotronik AG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Ackerstrasse 6, Bülach, 8180
Sources and methodology
- Original FDA record: P140030/S025
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



